James Gordon Herman
Impact in
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
- Molecular Biology top 0.01%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
Papers in
-
- Epigenetics and DNA Methylation 220
- Cancer-related gene regulation 117
- RNA modifications and cancer 60
- Histone Deacetylase Inhibitors Research 25
-
- Cancer Genomics and Diagnostics 51
- Co-authors
- Stephen B. Baylin (103 shared papers)Manel Esteller (56 shared papers)Jeremy Richard Graff (10 shared papers)S B Baylin (12 shared papers)Sanna Myöhänen (4 shared papers)Jean‐Pierre J. Issa (9 shared papers)B D Nelkin (1 shared paper)David Sidransky (19 shared papers)
- Journals
- Clinical Cancer Research (29 papers)Cancer Research (17 papers)Oncogene (16 papers)Blood (13 papers)Epigenetics (13 papers)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
James Gordon Herman
414 papers receiving 103.0k citations
James Gordon Herman's Hit Papers
Peers
Comparison fields: 5 of 190
- Cancer Research 21.5k
- Molecular Biology 63.7k
- Oncology 23.0k
- Genetics 7.7k
- Pathology and Forensic Medicine 10.5k
Countries citing papers authored by James Gordon Herman
This map shows the geographic impact of James Gordon Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Gordon Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Gordon Herman more than expected).
Fields of papers citing papers by James Gordon Herman
This network shows the impact of papers produced by James Gordon Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Gordon Herman. The network helps show where James Gordon Herman may publish in the future.
Co-authors
The 25 scholars most cited alongside James Gordon Herman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 418 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive genomic characterization defines human glioblastoma genes and core pathways Hit paper breakdown → | 2008 | 6384 |
| 2 | Integrated genomic analyses of ovarian carcinoma Hit paper breakdown → | 2011 | 6345 |
| 3 | Comprehensive molecular characterization of gastric adenocarcinoma Hit paper breakdown → | 2014 | 5209 |
| 4 | Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Hit paper breakdown → | 1996 | 5022 |
| 5 | Comprehensive molecular profiling of lung adenocarcinoma Hit paper breakdown → | 2014 | 4550 |
| 6 | Comprehensive genomic characterization of squamous cell lung cancers Hit paper breakdown → | 2012 | 3290 |
| 7 | Gene Silencing in Cancer in Association with Promoter Hypermethylation Hit paper breakdown → | 2003 | 2803 |
| 8 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2509 |
| 9 | Integrated Genomic Characterization of Papillary Thyroid Carcinoma Hit paper breakdown → | 2014 | 2442 |
| 10 | CpG island methylator phenotype in colorectal cancer Hit paper breakdown → | 1999 | 2141 |
| 11 | Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma Hit paper breakdown → | 2010 | 1943 |
| 12 | Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents Hit paper breakdown → | 2000 | 1876 |
| 13 | 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Hit paper breakdown → | 1995 | 1743 |
| 14 | A gene hypermethylation profile of human cancer. Hit paper breakdown → | 2001 | 1740 |
| 15 | Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia Hit paper breakdown → | 1997 | 1711 |
| 16 | Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Hit paper breakdown → | 1999 | 1642 |
| 17 | Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Hit paper breakdown → | 1998 | 1635 |
| 18 | DNA hypermethylation in tumorigenesis: epigenetics joins genetics Hit paper breakdown → | 2000 | 1400 |
| 19 | Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Hit paper breakdown → | 1994 | 1330 |
| 20 | Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Hit paper breakdown → | 1995 | 1196 |
About James Gordon Herman
James Gordon Herman is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Hematology, having authored 418 papers that have together received 105.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (220 papers), Cancer-related gene regulation (117 papers), RNA modifications and cancer (60 papers), Cancer Genomics and Diagnostics (51 papers), Genetic factors in colorectal cancer (46 papers), Histone Deacetylase Inhibitors Research (25 papers), Acute Myeloid Leukemia Research (25 papers) and Cancer-related Molecular Pathways (24 papers). The work is most often cited by research in Cancer Research (21.5k citations), Molecular Biology (63.7k citations), Oncology (23.0k citations), Genetics (7.7k citations) and Pathology and Forensic Medicine (10.5k citations). James Gordon Herman has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Stephen B. Baylin, Manel Esteller, Jeremy Richard Graff, S B Baylin, Sanna Myöhänen, Jean‐Pierre J. Issa, B D Nelkin, David Sidransky, Edward W. Gabrielson and Paul Gettys Corn. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Oncogene, Blood and Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.